SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011360
Filing Date
2024-08-07
Accepted
2024-08-07 16:15:29
Documents
65
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gbio-20240630x10q.htm   iXBRL 10-Q 1440730
2 EX-31.1 gbio-20240630xex31d1.htm EX-31.1 7621
3 EX-31.2 gbio-20240630xex31d2.htm EX-31.2 8138
4 EX-32.1 gbio-20240630xex32d1.htm EX-32.1 5104
5 EX-32.2 gbio-20240630xex32d2.htm EX-32.2 5083
  Complete submission text file 0001558370-24-011360.txt   5759465

Data Files

Seq Description Document Type Size
6 EX-101.SCH gbio-20240630.xsd EX-101.SCH 39035
7 EX-101.CAL gbio-20240630_cal.xml EX-101.CAL 44431
8 EX-101.DEF gbio-20240630_def.xml EX-101.DEF 177161
9 EX-101.LAB gbio-20240630_lab.xml EX-101.LAB 319849
10 EX-101.PRE gbio-20240630_pre.xml EX-101.PRE 273563
68 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20240630x10q_htm.xml XML 912639
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

IRS No.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39319 | Film No.: 241183972
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)